
Astral Systems raises £23M for fusion-based cancer isotopes
Bristol-based startup Astral Systems has raised £23 million to scale the production of medical isotopes using fusion technology. Unlike most fusion companies focused on energy, Astral is already generating revenue by applying fusion reactors to medical diagnostics.
The Next Web (TNW) · 105d ago





















